Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for AtriCure (ATRC) over the last 17 years, with Q3 2025 value amounting to $635.4 million.

  • AtriCure's Liabilities and Shareholders Equity rose 331.25% to $635.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 billion, marking a year-over-year increase of 113.11%. This contributed to the annual value of $609.3 million for FY2024, which is 74.99% down from last year.
  • According to the latest figures from Q3 2025, AtriCure's Liabilities and Shareholders Equity is $635.4 million, which was up 331.25% from $608.8 million recorded in Q2 2025.
  • AtriCure's 5-year Liabilities and Shareholders Equity high stood at $701.1 million for Q2 2021, and its period low was $581.9 million during Q3 2022.
  • Moreover, its 5-year median value for Liabilities and Shareholders Equity was $600.3 million (2023), whereas its average is $611.0 million.
  • Per our database at Business Quant, AtriCure's Liabilities and Shareholders Equity soared by 3262.4% in 2021 and then plummeted by 1641.93% in 2022.
  • Quarter analysis of 5 years shows AtriCure's Liabilities and Shareholders Equity stood at $615.3 million in 2021, then dropped by 4.85% to $585.4 million in 2022, then increased by 4.87% to $613.9 million in 2023, then decreased by 0.75% to $609.3 million in 2024, then rose by 4.29% to $635.4 million in 2025.
  • Its Liabilities and Shareholders Equity was $635.4 million in Q3 2025, compared to $608.8 million in Q2 2025 and $591.6 million in Q1 2025.